Cellectis
Short position disclosed on July 28, 2026.
1.00% of the capital sold short
2 disclosing funds
116 disclosures on record
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Oct 2025Jan 2026Apr 2026Jul 2026
March 30, 2015 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| GSA Capital Partners LLP | 0.50% | unchanged | February 7, 2023 | |
| Qube Research & Technologies Limited | 0.50% | new | July 28, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 17, 2015 | Oxford Asset Management LLP | 0.49% | December 21, 2015 |
| December 15, 2015 | Oxford Asset Management LLP | 0.50% | December 21, 2015 |
| December 9, 2015 | PFM Health Sciences, LP | 0.77% | March 16, 2016 |
| November 13, 2015 | PFM Health Sciences, LP | 0.93% | March 16, 2016 |
| November 12, 2015 | PFM Health Sciences, LP | 0.74% | March 16, 2016 |
| November 11, 2015 | PFM Health Sciences, LP | 0.63% | March 16, 2016 |
| November 10, 2015 | POINT72 Asset Management, L.P. | 0.43% | November 12, 2015 |
| November 6, 2015 | POINT72 Asset Management, L.P. | 0.57% | November 12, 2015 |
| November 4, 2015 | PFM Health Sciences, LP | 0.54% | March 16, 2016 |
| October 30, 2015 | PFM Health Sciences, LP | 0.68% | March 16, 2016 |
| October 15, 2015 | PFM Health Sciences, LP | 0.79% | March 16, 2016 |
| May 21, 2015 | Millennium International Management LP | 0.47% | May 25, 2015 |
| April 29, 2015 | Millennium International Management LP | 0.61% | May 25, 2015 |
| April 28, 2015 | Millennium International Management LP | 0.55% | May 25, 2015 |
| April 1, 2015 | Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.48% | April 3, 2015 |
| March 30, 2015 | Merrill Lynch, Pierce, Fenner & Smith Incorporated | 1.11% | April 3, 2015 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.32% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Cellectis, source AMF, data as at July 28, 2026, https://www.quivad.com/action/cellectis?page=3